

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Sharecast News) - Cancer treatment developer BiVictriX Therapeutics has secured a significant patent from the United States Patent and Trademark Offi...


(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.


(Alliance News) - Bivictrix Therapeutics PLC on Wednesday said it has been granted a US patent for lead asset BVX001.


(Alliance News) - Bivictrix Therapeutics PLC on Wednesday said it has raised GBP2.1 million through a placing and subscription of 16.4 million shares.


Bivictrix Therapeutics PLC on Wednesday - Macclesfield, England-based biotechnology company focusing on cancer therapies - Announces a proposed fundra...


(Alliance News) - BiVictriX Therapeutrics PLC announced on Monday that it had received positive final data from a second in vivo efficacy study of BVX...


Bivictrix Therapeutics PLC - Macclesfield, England-based biotechnology company focusing on cancer therapies - Posts positive interim data in its secon...